Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Molina Healthcare, Inc. (NYSE: MOH), a FORTUNE 500 company that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. These regulatory documents offer detailed insight into how Molina reports its operations, capital structure, and material events.
Among the key filings are Form 8-K current reports, where Molina discloses material developments. Recent 8-Ks describe the private offering of 6.500% Senior Notes due 2031, including interest terms, maturity, ranking, redemption features, and the related indenture. Other 8-Ks outline a new revolving credit facility, amendments to the company’s credit agreement, and a delayed draw term loan used to partially fund a stock repurchase program.
Additional 8-K filings furnish earnings releases for specific quarters, summarizing premium revenue, total revenue, net income, medical care costs, medical care ratios, and segment performance for Medicaid, Medicare, and marketplace operations. These reports also include reconciliations of non-GAAP measures such as adjusted net income, EBITDA, and Adjusted EBITDA, along with explanations of how these metrics are calculated and their limitations.
Investors can also review filings that discuss Medicaid and CHIP contract developments, such as the Notice of Agency Decision indicating an intent to award Molina Healthcare of Florida a Statewide Medicaid Managed Care and Children’s Health Insurance Program contract for the Children’s Medical Services Program. These documents help explain how new or renewed contracts may affect membership and premium revenue.
On Stock Titan, Molina Healthcare’s filings are updated as they are released on EDGAR, and AI-powered summaries highlight the main terms, financial impacts, and segment implications of each document. This allows users to quickly understand complex credit agreements, debt offerings, and earnings disclosures without reading every page of the underlying filing.
GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Leo P. Grohowski received a grant of 405 shares of common stock on April 1, 2026. The award was made under Molina Healthcare’s 2025 Equity Incentive Plan as part of his compensation for board service.
The filing states that directors receive an annual equity award valued at $220,000, with one quarter, or $55,000, granted on the first day of each quarter based on the closing share price. The closing price on April 1, 2026 was $135.82, resulting in the 405-share grant. Following this award, Grohowski directly holds 1,305 shares of Molina Healthcare common stock.
Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Stephen H. Lockhart received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant was valued at $55,000 based on a closing share price of $135.82, bringing his direct holdings to 4,147 shares.
This award represents one quarter of an annual equity grant of $220,000 provided to each director, with similar grants scheduled on the first day of each quarter using that day’s closing stock price.
ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 405 shares of common stock on April 1, 2026. The shares were awarded under Molina’s 2025 Equity Incentive Plan as part of his director compensation, based on the closing price of $135.82 per share that day, equating to a quarterly equity value of $55,000 toward an annual equity award of $220,000. After this grant, the Orlando Family Trust holds 17,730 shares of Molina common stock, and an additional 1,500 shares are held indirectly in the reporting person’s 401(k) plan.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with his board service. The award represents one quarterly installment of a $220,000 annual equity award, with this quarter’s $55,000 portion calculated using the April 1 closing price of $135.82 per share. Following this grant, indirect holdings for Wolf’s revocable trust increased to 15,396 shares of Molina Healthcare common stock.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard C. Zoretic received an equity grant of 405 shares of common stock on April 1, 2026, held by the Richard Charles Zoretic Revocable Living Trust. The grant was made under the company’s 2025 Equity Incentive Plan as part of his director compensation.
The shares were valued using the closing price of $135.82 on April 1, 2026, equating to a quarterly equity award of $55,000 and an annual equity award target of $220,000. Following this grant, the trust holds a total of 9,152 Molina Healthcare shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
MOLINA HEALTHCARE, INC. director Richard M. Schapiro received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The award represents one quarterly installment of a $220,000 annual equity grant, with this quarter’s $55,000 portion based on the $135.82 closing share price. Following the grant, Schapiro directly holds 12,074 common shares.
Molina Healthcare director Barbara L. Brasier received a grant of 405 shares of common stock as compensation for board service. The award was made on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The quarterly grant was valued at $55,000, based on the $135.82 closing price of Molina Healthcare stock that day. Brasier now directly holds 5,581 shares following this non‑market, compensation-related acquisition.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received an equity grant through a revocable trust. On April 1, 2026, the Ronna Romney Revocable Trust was awarded 405 shares of Molina Healthcare common stock at a reference price of $135.82 per share under the company’s 2025 Equity Incentive Plan. This quarterly grant represents one quarter of an annual director equity award valued at $220,000, structured as $55,000 in stock each quarter based on the closing market price that day. Following this award, the trust holds a total of 17,632 shares, reflecting routine, compensation-related ownership rather than an open-market purchase or sale.
Molina Healthcare Inc: The Vanguard Group filed an amended Schedule 13G/A reporting 0 shares and 0% beneficial ownership of common stock. The filing states an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report separately. The amendment is signed by Ashley Grim on 03/27/2026.